ArticleFrontiers in immunology2022

Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.

Maram Bawazir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.